Cycle-dependent expression of interleukin-1 receptor type II in the human endometrium

Biology of Reproduction

Volumn 65, Issue 3, 2001, Pages 890-898

  Boucher, A ^a   Kharfi, A ^a   Al Akoum, M ^a   Bossu P ^a   Akoum, A ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cytokines; Female reproductive tract; Menstrual cycle

Indexed keywords

INTERLEUKIN 1 RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMPLANTATION; MENSTRUAL CYCLE; MOLECULAR WEIGHT; OVULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

EID: 0034882785     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod65.3.890     Document Type: Article

References (42)

1. Biologic basis for interleukin-1 in disease
2. Interleukin-1 receptor antagonist: A new member of the interleukin-1 family
3. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
4. Interleukin 1 signaling occurs exclusively via the type I receptor
5. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex
6. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
7. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling
8. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types
9. The type II 'decoy' receptor: A novel regulatory pathway for interleukin 1
10. Identification of soluble interleukin-1 binding protein in cell-free supernatants: Evidence for soluble interleukin-1 receptor
11. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist
12. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1
13. Human endometrium: An active site of cytokine production and action
14. Predictive value of interleukin-1β in supernatants of human embryo culture
15. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in pre-implantation embryo culture fluid
16. Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes
17. Localization of interleukin-1 type I receptor and interleukin-1 beta in human endometrium throughout the menstrual cycle
18. Triphasic expression of interleukin-1 receptor type I in human endometrium throughout the menstrual cycle of fertile women and women suffering from unexplained infertility
19. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist
20. Structures-function relationship in the IL-1 family
21. Immunohistochemical localization, identification and regulation of the intereukin-1 receptor antagonist in the human endometrium
22. Dating the endometrial biopsy
23. Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis
24. Quantitative analysis of in situ hybridization methods for the detection of actin gene expression
25. Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis
26. Cytokines and embryo implantation
27. Role of metalloproteases in the release of the IL-1 type II decoy receptor
28. The membrane form of the type II IL-1 receptor accounts for inhibitory function
29. Molecular control of the implantation window
30. Potential implications of chemokines in reproductive function: An attractive idea
31. The impact of embryonic development and endometrial maturity on the timing of implantation
32. The implantation window: Basic and clinical aspects
33. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium
34. Integrin adhesion molecules in the human endometrium: Correlation with the normal and abnormal menstrual cycle
35. Embryonic regulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro
36. Increased plasma interleukin-1 activity in women after ovulation
37. Normal human endometrium expresses the decoy interleukin-1 receptor type II and shows a defective expression of the receptor in women with endometriosis
38. Site and menstrual cycle-dependent expression of proteins of the tumor necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNFα in human endometrium
39. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis
40. Interleukin receptor mRNA expression in activated bovine leukocytes in vitro
41. Interleukin-1 (IL-1) beta-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta 1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: Implications to IL-1beta feedback systems and cytokine-cytokine interactions